Tumor vascular normalization as a strategy to potentiate effectiveness of therapeutic vaccines

Ítems similars

• Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines
  per: Farsaci, Benedetto, et al.
  Publicat: (2014)
• Effects of tyrosine kinase inhibitors alone or in combination with vaccine on tumor-infiltrating myeloid cells
  per: Donahue, Renee N, et al.
  Publicat: (2013)
• PD-L1 and MHC-I expression in 19 human tumor cell lines and modulation by interferon-gamma treatment
  per: Grenga, Italia, et al.
  Publicat: (2014)
• PD-1 and PD-L1 expression on PBMC subsets in normal individuals and cancer patients
  per: Lepone, Lauren, et al.
  Publicat: (2014)
• Identification of tumor associated immune responses against brachyury, a transcription factor and driver of EMT, in chordoma patients receiving a yeast-brachyury vaccine (gi-6301)
  per: Donahue, Renee N, et al.
  Publicat: (2014)